ArticleAnnals of surgery2026
Frequency and Natural History of Emergency General Surgery Conditions in Cancer Patients: A SEER-medicare Population Analysis.
Article in Annals of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo determine if cancer patients experience variability in incidence or management of emergency general surgery (EGS) conditions compared tononcancer patients.
backgroundThe true frequency and natural history of EGS conditions among cancer patients have not been characterized.
methodsWe utilized surveillance, epidemiology, and end results-medicare data from January 2006 to December 2016 to compare patients with breast, prostate, and lung cancer to a noncancer cohort. Patients were followed from the date of cancer diagnosis, or index date for noncancer patients, to the development of an EGS condition, death, or last follow-up. We assessed the cumulative incidence of EGS conditions over time, and fit multivariable Cox proportional hazards models to evaluate the impact of time-dependent surgical intervention on mortality.
resultsWe identified 322,756 patients with breast (N=82,147), lung (N=128,618), and prostate cancer (N=111,991) and 210,429 noncancer patients. Cancer patients had a higher incidence of an EGS condition within the first year after diagnosis (4.8% vs 3.2%), with lung (6.8%) and breast cancer (4.0%) showing consistent trends. Cancer patients were less likely to undergo surgery (13% vs 14%, P =0.005), though this varied by cancer type and EGS conditions. Patients with breast (HR: 1.27, 95% CI: 1.17-1.39) and lung cancer (HR: 3.27, 95% CI: 3.07-3.48) were more likely to die within 30 days of an EGS diagnosis.
conclusionsCancer patients experience a higher incidence of EGS conditions within the first year following diagnosis but are less likely to undergo surgery. Future research is needed to explore the interplay between EGS conditions, their management, receipt of intended oncologic therapy, and resulting outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.